Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

JEFFERSON HEALTH - NORTHEAST

NPI: 1801963343 · PHILADELPHIA, PA 19114 · General Acute Care Hospital · NPI assigned 11/29/2006

$5.50M
Total Medicaid Paid
121,690
Total Claims
102,920
Beneficiaries
183
Codes Billed
2019-10
First Month
2024-12
Last Month

Provider Details

Authorized OfficialGALUP, RICHARD (PRESIDENT)
NPI Enumeration Date11/29/2006

Related Entities

Other providers sharing the same authorized official: GALUP, RICHARD

ProviderCityStateTotal Paid
JEFFERSON HEALTH - NORTHEAST PHILADELPHIA PA $14.48M
JEFFERSON HEALTH - NORTHEAST LANGHORNE PA $1.71M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2019 201 $5K
2020 21,051 $1.10M
2021 54,851 $2.62M
2022 12,375 $559K
2023 14,750 $479K
2024 18,462 $742K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0378 Hospital observation service, per hour 1,710 983 $1.12M
99284 Emergency department visit for the evaluation and management, high severity 6,135 5,891 $1.05M
99283 Emergency department visit for the evaluation and management, moderate severity 5,635 5,397 $1.01M
78815 Positron emission tomography (PET) for limited area imaging 492 483 $392K
62323 385 369 $223K
77067 Screening mammography, bilateral, including computer-aided detection 2,296 2,272 $212K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 1,700 1,637 $183K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1,220 1,178 $157K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 1,904 1,827 $131K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 688 422 $78K
99282 Emergency department visit for the evaluation and management, low to moderate severity 530 512 $69K
76642 1,336 1,267 $67K
77063 Screening digital breast tomosynthesis, bilateral 2,311 2,272 $54K
74177 Computed tomography, abdomen and pelvis; with contrast material 847 825 $51K
T1015 Clinic visit/encounter, all-inclusive 406 146 $47K
77066 Tomosynthesis, mammo 449 444 $44K
95886 541 507 $35K
77065 Tomosynthesis, mammo 368 349 $26K
71046 Radiologic examination, chest; 2 views 1,808 1,758 $23K
36000 799 775 $23K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 164 54 $21K
0001A 433 433 $20K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 738 727 $19K
0002A 333 333 $19K
94729 632 627 $19K
76641 322 282 $18K
70450 Computed tomography, head or brain; without contrast material 1,143 1,097 $18K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 442 428 $17K
94726 612 608 $16K
76830 Ultrasound, transvaginal 333 329 $16K
76700 Ultrasound, abdominal, real time with image documentation; complete 254 250 $15K
94060 674 666 $15K
J1439 Injection, ferric carboxymaltose, 1 mg 19 12 $15K
97161 241 229 $15K
71260 Computed tomography, thorax, diagnostic; with contrast material 355 347 $13K
96375 Therapeutic injection; each additional sequential IV push 1,325 1,012 $12K
76770 257 250 $12K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 370 302 $11K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 3,397 3,285 $11K
80048 Basic metabolic panel (calcium, ionized) 4,854 4,014 $11K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 3,047 2,744 $9K
95909 216 212 $8K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 165 165 $8K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 264 256 $8K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 5,518 4,685 $8K
72125 Computed tomography, cervical spine; without contrast material 500 481 $7K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1,681 1,554 $7K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 93 90 $7K
71250 122 120 $7K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 481 433 $6K
73630 417 363 $5K
76536 93 88 $4K
74176 Computed tomography, abdomen and pelvis; without contrast material 94 90 $4K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 27 27 $4K
70486 150 144 $4K
72100 173 171 $4K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 465 454 $4K
71275 Computed tomographic angiography, chest, with contrast material 74 72 $4K
97803 82 82 $4K
71045 Radiologic examination, chest; single view 1,137 1,084 $3K
0004A 63 63 $3K
C1769 Guide wire 137 132 $3K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 773 602 $3K
77336 66 28 $3K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 194 185 $3K
84484 1,499 1,267 $3K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 14 14 $3K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 210 203 $3K
93971 72 71 $3K
A9585 Injection, gadobutrol, 0.1 ml 161 156 $3K
77080 53 53 $3K
73030 218 198 $2K
73610 207 179 $2K
77061 78 76 $2K
85730 1,169 1,100 $2K
80053 Comprehensive metabolic panel 695 574 $2K
0012A 31 31 $2K
95911 28 28 $2K
76000 217 210 $2K
73564 198 172 $2K
73130 191 160 $2K
70551 Magnetic resonance imaging, brain; without contrast material 12 12 $2K
80076 1,092 1,015 $1K
0003A 19 19 $1K
85610 1,302 1,232 $1K
76705 Ultrasound, abdominal, real time with image documentation; limited 27 27 $1K
88305 Level IV - Surgical pathology, gross and microscopic examination 275 264 $962.27
85027 561 473 $904.09
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 175 168 $898.83
0011A 36 36 $890.96
90715 180 176 $795.99
96361 Intravenous infusion, hydration; each additional hour 349 315 $787.25
84443 Thyroid stimulating hormone (TSH) 327 301 $782.81
77062 30 30 $762.28
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 502 488 $751.99
83735 1,022 837 $740.70
86900 482 463 $720.02
97802 12 12 $714.82
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 34 25 $714.75
86850 436 424 $707.80
G0463 Hospital outpatient clinic visit for assessment and management of a patient 38 36 $668.38
83690 893 831 $658.03
76376 31 31 $654.16
76801 13 12 $613.57
J2704 Injection, propofol, 10 mg 2,223 2,130 $597.24
93975 14 14 $585.69
80320 176 171 $566.37
82805 54 51 $543.64
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 116 111 $510.78
86901 458 443 $442.22
83880 115 110 $440.71
73562 18 12 $399.86
72040 24 24 $379.35
84702 108 105 $363.50
81003 781 751 $339.48
J3490 Unclassified drugs 3,153 1,989 $328.86
A9270 Non-covered item or service 7,049 1,985 $318.75
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 71 43 $311.89
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 966 941 $306.14
83605 316 291 $292.36
85379 195 185 $287.03
96367 23 13 $254.85
84703 125 123 $245.42
80329 92 88 $221.08
73110 30 24 $209.59
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 143 135 $203.06
81001 471 451 $181.71
J2270 Injection, morphine sulfate, up to 10 mg 883 701 $176.19
82962 557 382 $165.03
36415 Collection of venous blood by venipuncture 976 750 $162.18
J1100 Injection, dexamethasone sodium phosphate, 1 mg 2,141 1,561 $161.30
99152 78 75 $159.90
87086 Culture, bacterial; quantitative colony count, urine 100 97 $150.73
J7030 Infusion, normal saline solution , 1000 cc 618 549 $146.74
J3010 Injection, fentanyl citrate, 0.1 mg 2,853 2,377 $137.92
87088 136 132 $120.86
73502 14 14 $113.37
73590 12 12 $99.30
J0690 Injection, cefazolin sodium, 500 mg 801 655 $78.29
83036 Hemoglobin; glycosylated (A1C) 115 110 $77.29
J1885 Injection, ketorolac tromethamine, per 15 mg 2,904 2,572 $71.92
J1644 Injection, heparin sodium, per 1000 units 716 431 $69.94
J1170 Injection, hydromorphone, up to 4 mg 237 159 $67.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 3,303 2,744 $51.92
J1200 Injection, diphenhydramine hcl, up to 50 mg 650 504 $47.43
J2405 Injection, ondansetron hydrochloride, per 1 mg 2,918 2,536 $46.72
82550 54 48 $41.36
84100 127 93 $37.81
J2250 Injection, midazolam hydrochloride, per 1 mg 2,269 2,148 $37.09
J1815 Injection, insulin, per 5 units 488 211 $29.34
87040 12 12 $28.00
99153 Mod sedat endo service >5yrs 17 15 $24.32
80061 Lipid panel 43 41 $21.85
88307 13 12 $18.63
J1956 Injection, levofloxacin, 250 mg 31 27 $7.10
81025 26 26 $6.89
S0028 Injection, famotidine, 20 mg 28 26 $4.00
J0696 Injection, ceftriaxone sodium, per 250 mg 235 203 $3.78
J2765 Injection, metoclopramide hcl, up to 10 mg 80 76 $3.39
J2060 Injection, lorazepam, 2 mg 52 43 $2.84
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 104 80 $0.60
91300 181 167 $0.08
96376 350 274 $0.00
J2469 Injection, palonosetron hcl, 25 mcg 662 400 $0.00
88342 12 12 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 117 102 $0.00
86140 16 12 $0.00
J7999 Compounded drug, not otherwise classified 112 90 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 13 12 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 46 45 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 348 243 $0.00
J1650 Injection, enoxaparin sodium, 10 mg 617 374 $0.00
J1756 Injection, iron sucrose, 1 mg 956 425 $0.00
87186 48 46 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 15 13 $0.00
J1453 Injection, fosaprepitant, 1 mg 53 39 $0.00
87631 58 58 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 220 192 $0.00
C1758 Catheter, ureteral 12 12 $0.00
J1171 Injection, hydromorphone, 0.1 mg 15 12 $0.00
J9271 Injection, pembrolizumab, 1 mg 82 73 $0.00
J2004 Injection, lidocaine hcl with epinephrine, 1 mg 38 37 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 28 27 $0.00